Recently, Branson and coworkers reported a strong association between binge-eating disorder (BED) and variants in the melanocortin-4 receptor gene (MC4R). In the current study, we compared the eating behavior of 43 obese probands with functionally relevant MC4R mutations and of 35 polymorphism carriers (V103I or I251L) with wild-type carriers. The module for eating disorders of the Composite International Diagnostic Interview was used to identify binge-eating behavior. The Three-Factor Eating Questionnaire and the Leeds Food Frequency Questionnaire were used to assess restrained eating, disinhibition, hunger and percent total energy intake as fat. No significant differences between carriers of MC4R variants and wildtype carriers were detected. In particular, we found no evidence for an increased rate of bingeeating behavior in obese carriers of MC4R variants. Our findings do not support the strong association between BED and MC4R carrier status. Keywords: fat intake; obesity; bulimia nervosa; eating disorders; MC4R
The melanocortinergic system is involved in energy homeostasis and body weight regulation. [1] [2] [3] The melanocortin-4 receptor gene (MC4R) is expressed in the hypothalamus; both a-and b-melanocyte-stimulating hormone (MSH) can act as agonists and induce satiety and an elevated energy expenditure; 4 agoutirelated peptide (AGRP) also binds to this receptor as an antagonist/inverse agonist and stimulates feeding. 5, 6 The importance of the MC4R for body weight regulation was demonstrated in vivo by the occurrence of hyperphagia and obesity in MC4R knockout mice, which additionally show an increased length and hyperinsulinemia. [7] [8] [9] Heterozygous mice have a body weight intermediate between Mc4r
À/À and wildtype mice. 7, 9 In the first human studies, MC4R mutations were detected in extremely obese individuals only. [10] [11] [12] Since then, frameshift, nonsense and missense mutations have been identified in several obese study groups of different ethnicity. 3 All of these mutations occur infrequently; among extremely obese individuals heterozygosity rates are below 1% for any single mutation, several of which have been observed only once worldwide. 3 Functional studies have shown that most of these mutations, over 30 of which have been reported, lead either to total or partial loss of function. [13] [14] [15] [16] 3 Between 2 and 4% of extremely obese individuals harbor such mutations. 3 The two missense variants V103I and I251L, which occur in approximately 3 and 1% of the probands investigated as of today, do not predispose to obesity; similar allele frequencies have been detected in both cases and controls. 17 Pedigree analyses revealed that mutations proven to be functionally relevant in vitro underlie co-dominantly inherited obesity. [16] [17] [18] Similar to the findings in Mc4r À/À mice, the degree of adiposity in homozygotes and compound heterozygotes exceeds that of heterozygous carriers. 19, 17, 3 Within families ascertained via an obese MC4R mutation carrier, heterozygotes have infrequently been shown to be nonobese or even lean. [16] [17] [18] Recently, Branson et al 20 identified 24 carriers of MC4R variants among 469 severely obese patients consecutively referred to a clinic for their refractory obesity. The respective variants encompassed five missense mutations and one silent variant; additionally, an 1419A4G substitution was detected in the 3 0 untranslated region. The two polymorphisms V103I and I251L accounted for the remaining 16 carriers. Stringently diagnosed binge-eating disorder (BED) was present in all 20 (100%) of the 24 obese carriers of MC4R variants, for whom relevant phenotypical data were available in contrast to only 14.2% among those 120 obese noncarriers matched for age, sex and BMI. One out of 25 normal-weight controls was also heterozygous for the V103I polymorphism.
We had previously observed BED and bulimia nervosa (BN) in single mutation carriers. 18, 21 We had discussed that MC4R mutations might directly induce binge-eating episodes implying a causal link, wherein binge eating represents a form of (severe) hyperphagia. 21 Alternatively, BED or BN might merely represent epiphenomena of the (extreme) obesity present in mutation carriers. In the current study, we assessed the eating behavior and, in particular, binge eating in a total of 43 carriers of potentially functionally relevant MC4R mutations.
Materials and methods

Study groups
Our three study groups were based on a total of 1041 children and adolescents with obesity (BMI Z90th centile), who had been screened for mutations in the MC4R.
3 Study group A comprised those 208 adolescents aged Z13 years, who were interviewed with the eating disorders module of the Munich Composite Diagnostic Interview (M-CIDI 22 ). Study group B included those 529 parents of the 1041 children, who were both screened for mutations and interviewed. Finally, study group C encompassed 77 s or higher degree relatives of those obese children and adolescents, who either themselves or one of whose parents had a MC4R mutation and consented to be interviewed and genotyped. As all mutation carriers had indicated that they wanted to be re-contacted in case of a positive finding upon the initial assessment, we were able to get in touch with all mutation carriers (excluding carriers of either one of the polymorphisms) and obtained permission to also contact additional family members. In this manner, 26 extended pedigrees were recruited and all participating relatives were also screened by SSCP 3 of the complete coding region (twice, independently) and independent mutation analyses (PCR-RFLP and ARMS-PCR). Written informed consent was given by participants, or in case of minors by their parents.
Assessment of binge-eating behavior
All subjects were interviewed with the module for eating disorders of the M-CIDI, 22 which begins with the screening question for binge-eating episodes 0 Have you ever had a time when you would eat abnormally large amounts of food within a few hours-that is, eat in binges?'. Individuals who screened negatively were not interviewed further, those with a positive response were then questioned as to the lifetime occurrence of BN symptoms as based on DSM-III-R; 23 identical to DSM-IV 24 criteria with particular emphasis on the A and D criteria for BN: the DSM-IV A criterion for BN, which defines a binge-eating episode, is identical to the DSM-IV A research criterion for BED, the DSM-IV C criterion for BN ('the binge eating and inappropriate compensatory behaviors both occur, on average, at least twice a week for 3 months') in turn partially overlaps with the D criterion for BED ('the binge eating occurs, on average, at least 2 days a week for 6 months').
Three-Factor Eating Questionnaire (TFEQ) group: A total of 130 individuals screened for MC4R mutations from 26 pedigrees based on MC4R mutation carriers filled in the German version of the TFEQ. 25, 26 Fat intake group: A total of 48 individuals screened for MC4R mutations from 17 of the aforementioned 26 pedigrees filled in the German version of the Leeds Food Frequency Checklist. 27 
Statistical analyses
The Quantitative Transmission Disequilibrium Test (Q-TDT 28 ), a generalization of the TDT for quantitative phenotypes in general pedigrees, was used to analyze the answers from the TFEQ. The dependency of the three factors on BMI and sex was accounted for by including standard deviation scores for BMI and sex as covariates in the model. Since the phenotypes were not normally distributed, significance was tested by a randomization test. Age-, sex-and BMIadjusted logistic regression analyses were performed for mutation carriers screening positively for binge eating, and additionally fulfilling criterion A and/or criterion C, respectively.
An analysis of covariance was performed to analyze the effect of the MC4R mutations on fat intake. Sex and BMI (SDS values) were included as covariates.
Results
All the three study groups combined (n ¼ 814) encompassed 43 carriers of potentially functionally relevant MC4R mutations. The percentages of individuals, who screened positively for binge-eating episodes and fulfilled the A and C criteria for BN, respectively, were similar in carriers and noncarriers; slightly higher rates were obtained for noncarriers (Table 1) . Age-, sex-and BMI-adjusted logistic regression analyses for the group of 208 obese children and adolescents resulted in odds ratios of 0.61 (95% CI: 0.11-3.39, P ¼ 0.58), 0.92 (95% CI: 0.17-5.15, P ¼ 0.93) and 0.44 (95% CI: 0.05-4.17, P ¼ 0.48) for mutation carriers screening positively for binge eating, and additionally fulfilling criterion A and/or criterion C, respectively. We were not able to perform these analyses for groups B and C, due to the nonoccurrence of binge eating in the respective mutation carriers.
Our additional analyses using the quantitative transmission disequilibrium test (Q-TDT) pertaining to eating behavior in relatives of obese MC4R mutation carriers revealed no systematic differences between mutation and wild-type carriers with respect to the scores of the three scales (cognitive restraint, disinhibition, hunger) of the TFEQ 25 adjusted for BMI-standard deviation scores (all P-values 40.2). Finally, assessment of fat intake as percent of total energy intake as determined with the Leeds Food : 'Have you ever had a time when you would eat abnormally large amounts of food within a few hours-that is, eat in binges?' c
The DSM-IV C-criterion for BN ('the binge eating and inappropriate compensatory behaviors both occur, on average, at least twice a week for 3 months') partially overlaps with the D criterion for BED ('the binge eating occurs, on average, at least 2 days a week for 6 months').
Frequency Questionnaire 27 in a covariance analysis revealed no difference between mutation and wildtype carriers (P-value ¼ 0.79).
Discussion
In light of the 100% association between carrier status and BED in the study of Branson et al and our negative results, 20 the following issues appear relevant:
(1) We based our analyses on carriers of mutations, which have all been shown to be functionally relevant in vitro; 3, 13 in contrast, functional studies were not performed by Branson and coworkers. 20 We did not include carriers (a) of silent variants in the open reading frame (ORF), (b) of variants in untranslated regions and (c) of the V103I and I251L polymorphisms; in the Branson et al study, polymorphism carriers accounted for 16 of the 24 carriers of MC4R variants in the obese study group. In our opinion, the exclusion of silent variants in the ORF and the two polymorphisms is warranted because they have not been shown to be functionally relevant in in vitro assays 16, 29, 30 and they occur with similar frequency among obese cases and controls. 17 If, nevertheless, these polymorphisms induce binge eating, it is evident that a straightforward explanation for the underlying mechanism does not exist. In order to exclude the remote possibility that our classification of polymorphism carriers as noncarriers contributes to the discrepant findings, we post hoc also analyzed the response to the screening question of the eating disorders module of the CIDI. Of the eight, 24 and three polymorphism carriers (V103I or I251L) in groups A, B and C, respectively, four in group A and none in the other groups screened positively for binge-eating episodes. Thus, no evidence for an association between binge-eating behavior and polymorphism carrier status was detected in our study groups. (2) Power calculations based on the differences reported by Branson et al (100% BED in mutation carriers vs 14.2% BED in noncarriers) revealed that our analyses had a power of more than 99% for the comparisons within the three groups. (3) The difficulties inherent to diagnosing BED are well known. 31 Whereas Branson et al 20 used an extensive diagnostic procedure including independent interviews by a certified dietitian and a psychologist to reach a diagnosis of BED, we relied on the eating disorders module of the M-CIDI. 22 This module was devised to allow a diagnosis of BN only. However, as pointed out above, the A criteria for both eating disorders are identical and the C and D criteria for BN and BED, respectively, partially overlap. It is readily evident that our diagnostic assessment is crude in comparison to the stringent approach chosen by Branson et We conclude that binge-eating episodes are not a distinct feature of MC4R mutation carriers. This is consistent with a previous study in which we found no MC4R mutations in 30 obese subjects with BED. 33 We have no plausible explanation for the strong association reported by Branson et al; 20 we additionally found no evidence that carriers of the V103I and I251L polymorphisms are predisposed to binge-eating episodes. From our point of view, single patients with eating disorders can indeed harbor functionally relevant MC4R mutations. 18, 21 If no causal relationship exists, the rate of BED or BN should be comparable between obese individuals with or without MC4R mutations. Based on our own efforts pertaining to ascertainment, genotyping and phenotypical characterization, we realize that large sample sizes are required to assess, if and to what extent the BED rate is elevated in carriers of MC4R variants. We found additionally no evidence for a deviant fat intake or eating behavior, as assessed with the TFEQ in MC4R mutation carriers.
